Imagine relying on a medical device that could potentially miss a life-threatening condition simply because of your skin color. This is the alarming reality uncovered by a groundbreaking study published in The BMJ today. Researchers have found that pulse oximeters—those handy fingertip devices used at home to monitor blood oxygen levels—consistently overestimate oxygen levels in patients with darker skin tones. But here's where it gets controversial: this oversight could lead to delayed treatment for those who need it most, while potentially subjecting lighter-skinned individuals to unnecessary medical interventions.
Pulse oximeters work by shining light through the skin to measure the amount of oxygen in the blood, typically expressed as SpO2. A normal reading falls between 95% and 100%, with anything below 90-92% signaling hypoxaemia—a condition requiring immediate medical attention. However, the study reveals that darker skin pigmentation can absorb more light, tricking the device into reporting higher oxygen levels than actually exist. And this is the part most people miss: while previous studies hinted at this issue, none have provided such conclusive evidence—until now.
To investigate, researchers analyzed data from 903 critically ill adults across 24 NHS intensive care units in England between June 2022 and August 2024. They compared pulse oximeter readings (SpO2) with gold-standard arterial blood gas measurements (SaO2) and objectively assessed skin tone using a spectrophotometer. The results were striking: all five pulse oximeters tested consistently showed SpO2 readings 0.6-1.5 percentage points higher for darker-skinned patients compared to lighter-skinned ones, regardless of actual oxygen levels.
Here’s the kicker: at critical thresholds—94% or lower (indicating the need for medical help) and 92% or lower (requiring emergency care)—false negative rates (missed low oxygen) increased with darker skin tones, while false positive rates (incorrectly flagged low oxygen) decreased. Though these differences may seem small, they can have significant clinical implications, potentially leading to underdiagnosis of hypoxaemia in darker-skinned individuals.
While this observational study cannot prove causation, its large scale and sophisticated statistical modeling make its findings hard to ignore. The researchers emphasize that SpO2 readings should not be interpreted in isolation, especially for darker-skinned patients, and that trends over time are more reliable than single measurements. They also call for healthcare systems to develop clear guidance to address this disparity, particularly in settings where additional clinical data may not be available.
In a linked editorial, experts agree that clinicians must approach pulse oximeter readings for darker-skinned patients with caution. They argue that regulation must evolve to ensure these devices do not perpetuate health inequalities. The goal, they stress, is not to discard pulse oximetry but to refine it, making it a fair and reliable tool for everyone.
But here’s the question that lingers: How many patients have already been affected by this oversight, and what can we do to prevent further harm? Share your thoughts in the comments—do you think current medical technologies are doing enough to account for racial and ethnic differences, or is there still a long way to go?
